Envista Holdings Corporation - NVST STOCK NEWS

Envista Holdings Corporation (NYSE: NVST) announced a definitive agreement to acquire Carestream Dental's Intra-Oral Scanner business for $600 million, expected to close in Q2 2022. This acquisition aligns with Envista's strategy to capture high-growth segments in the dental market, featuring anticipated annual sales of $60 million in 2021. The acquisition is set to enhance Envista's offerings in digital dental workflows, leveraging world-class intra-oral scanners critical for procedures like implants and prosthetics. The transaction is subject to regulatory approvals.

Envista Holdings Corporation (NYSE: NVST) announced its participation in several upcoming investor conferences. Key events include the Stifel MedTech Madness on December 15, 2021, the Goldman Sachs Healthcare CEOs Unscripted Conference on January 6, 2022, and the J.P. Morgan Healthcare Conference on January 10, 2022. Investors can access recordings of these presentations on Envista's Investor Relations website. As a leading global dental products company, Envista operates over 30 trusted dental brands and aims to enhance patient care through innovative solutions.

Envista Holdings Corporation (NYSE: NVST) reported a strong third quarter 2021, achieving sales of $607.3 million, an 11% increase, with core sales growing 10.2% year-over-year. Net income was $80.2 million or $0.45 per diluted share. The company raised its full-year guidance for sales to $2.475 - $2.500 billion and adjusted EBITDA to $480 - $495 million. CEO Amir Aghdaei expressed optimism for the dental industry, noting a focus on differentiated products and strong digital solutions. Adjusted EBITDA margin stood at 19.6%, highlighting profitability.

Envista Holdings Corporation (NYSE: NVST) will report its third quarter 2021 financial results on November 3, 2021. A conference call to discuss these results is scheduled for 2:00 PM PT, lasting approximately one hour. Investors can access the call by dialing 877-876-9173 for U.S. participants or +1 785-424-1667 internationally. The call will also be available via webcast on Envista's website, with a replay accessible after the presentation. Detailed materials will be posted prior to the call.

Envista Holdings Corporation (NYSE: NVST) announced the sale of its KaVo Treatment Unit and Instrument business to Planmeca for up to $455 million, including a $30 million earn-out. This divested segment generated $357 million and $317 million in revenue in fiscal years 2019 and 2020, respectively. The deal is expected to close by the end of 2021 and will be reported as a discontinued operation starting Q3 2021. The transaction is not dependent on financing or a shareholder vote.

Envista Holdings Corporation (NYSE: NVST) announced its participation in the Baird Global Healthcare Virtual Conference on September 14, 2021, at 2:35 PM ET. Investors can access the presentation via Envista's Investor Relations website under the Events and Presentations section. Envista is a leading global provider of dental products, boasting over 30 trusted brands, including KaVo Kerr and Nobel Biocare. The company focuses on innovation and customer support to address dental professionals' needs.

Envista Holdings (NYSE: NVST) reported strong Q2 2021 results with sales reaching $740.1 million, a remarkable increase of 104.4% year-over-year. Core sales growth was 102.3%, outpacing pre-pandemic levels by 5.6% compared to Q2 2019. Net income stood at $90.1 million or $0.51 per diluted share, with adjusted EBITDA soaring to $140.4 million. The company’s adjusted EBITDA margin was 19%. Looking ahead, Envista projects full-year sales between $2.8 billion and $2.9 billion and maintains a high-teens adjusted EBITDA margin.

Envista Holdings Corporation (NYSE: NVST) announced the launch of the Envista Smile Project, a non-profit oral health foundation aimed at improving dental care access for disadvantaged communities. Currently applying for Section 501(c)(3) status, the foundation focuses on collaboration with dental professionals and Envista employees to provide care and education worldwide. CEO Amir Aghdaei emphasized the project's mission of enhancing quality of life through oral health support. This initiative aligns with Envista's broader commitment to dental care innovation and community service.

Envista Holdings Corporation (NYSE: NVST) will announce its second quarter 2021 financial results on August 3, 2021, with a conference call at 2:00 PM PT. The call will feature a discussion of these results and will last approximately one hour. Investors can access the call by dialing 866-342-8588 (U.S.) or +1 203-518-9865 (international), using conference ID #8094612. Webcast materials will be available on Envista's website before the call, with a replay accessible later.